Anti-Microbial Resistance (AMR): india's ticking time bomb & new policy solutions

Anti-Microbial Resistance (AMR) represents one of the most significant public health challenges of the 21st century, threatening to reverse a century of medical progress. It occurs when microorganisms such as bacteria, viruses, fungi, and parasites evolve and no longer respond to medicines (like antibiotics), making infections harder to treat and increasing the risk of disease spread, severe illness, and death. This phenomenon, often called the “silent pandemic,” is accelerating globally, with India at its epicenter due to a combination of factors.

The primary drivers of AMR are the misuse and overuse of antimicrobials. In the human health sector, this includes the prescription of unnecessary antibiotics for viral infections, failure to complete prescribed treatment courses, and the unregulated over-the-counter availability of antibiotics.

Fun Fact: Alexander Fleming, the discoverer of penicillin, warned of antibiotic resistance in his 1945 Nobel Prize lecture. He noted that “the ignorant man may easily underdose himself and by exposing his microbes to non-lethal quantities of the drug make them resistant.”

A significant, often overlooked, contributor is the agricultural sector. Antibiotics are extensively used in livestock, poultry, and aquaculture, not just to treat sick animals but also as growth promoters to increase meat production. This non-therapeutic use creates a massive reservoir of resistant bacteria that can be transmitted to humans through the food chain or environmental contamination.

India’s Strategic Response: The ‘One Health’ Approach

Recognizing the multifaceted nature of the problem, India launched its National Action Plan on Anti-Microbial Resistance (NAP-AMR) in 2017. The plan is critically aligned with the ‘One Health’ approach, a global strategy that acknowledges the deep interconnection between the health of people, animals, and their shared environment. The NAP-AMR is built on six strategic pillars.

To remember these pillars, you can use the following mnemonic:

Mnemonic: “Aware Knowledge Inhibits Overuse, Requiring Innovation” (Awareness, Knowledge, Infection Prevention, Optimize Use, Research, Investment)

Recent Developments and Policy Momentum (2024-2025)

The fight against AMR is dynamic, and India has seen significant policy discussions and actions in the last 18 months.

• Strengthening Surveillance: In early 2025, the Indian Council of Medical Research (ICMR) significantly expanded its AMR Surveillance Network, adding 50 new labs in Tier-II and Tier-III cities. This move addresses critical data gaps and aims to provide a more granular, nationwide picture of resistance patterns. Data from 2024 had already revealed alarming resistance levels to last-resort antibiotics like carbapenems, making this expansion crucial.
• Focus on Animal Health: A 2024 report by the Federation of Indian Animal Protection Organisations (FIAPO) highlighted the continued misuse of antibiotics in the poultry industry. This has put pressure on the government to strictly enforce existing bans on drugs like colistin as growth promoters and improve regulation in the animal husbandry sector.
• Legislative Push: A draft “Pharmacy (Amendment) Bill, 2024” is under discussion to bring stricter controls on the dispensing of Schedule H1 drugs, which include most advanced antibiotics. The bill proposes a digital framework for tracking prescriptions to curb rampant over-the-counter sales, a major driver of resistance.
• Operationalizing ‘One Health’: The newly launched National One Health Mission has a dedicated vertical for combating AMR. Its 2025 budget allocation is focused on empowering state-level One Health committees to effectively implement the NAP-AMR, ensuring better coordination between human, animal, and environmental health departments.

Analogy: Treating our limited supply of effective antibiotics like a non-renewable resource is crucial. Every unnecessary dose is like burning a fossil fuel—it contributes to a future crisis and cannot be easily undone.

Critical Policy Appraisal

Analytical Lens: UPSC Focus (Mains & Prelims)

Conceptual Basis

The foundational policy document for this topic is the National Action Plan on AMR (2017), which is India’s response to the WHO’s Global Action Plan on Antimicrobial Resistance (2015). The core legal and ethical principle is the ‘One Health’ framework, which is now being institutionalized through the National One Health Mission.

UPSC Integration: Connecting the Dots

• GS Paper 2 (Polity & Governance): This topic directly relates to Health Policy, Regulatory Bodies (like the Central Drugs Standard Control Organisation), and the challenges of Cooperative Federalism in implementing national health programs.
• GS Paper 3 (Economy & S&T): AMR has severe implications for the economy through increased healthcare costs and loss of human capital productivity. It also connects to the pharmaceutical industry, animal husbandry, and the role of Biotechnology in developing new diagnostics and drugs.
• GS Paper 1 (Society): The issue impacts public health behavior, poverty (due to catastrophic health expenditure), and food safety.

Expert Analysis: Future Impact

The long-term impact of unchecked AMR is catastrophic, threatening to make routine surgeries, cancer chemotherapy, and organ transplants life-threateningly risky. Economically, it could shave off several percentage points from global GDP and push millions into extreme poverty. For India, successfully tackling AMR is not just a public health imperative but a strategic necessity to protect its demographic dividend and achieve its economic ambitions. The ‘One Health’ approach is the only viable path forward, requiring a paradigm shift from siloed governance to an integrated, systems-thinking model.

Prelims Practice Question (MCQ)

Question: The “Red Line Campaign,” frequently mentioned in the context of Indian public health, is primarily aimed at: (a) Promoting voluntary blood donation drives. (b) Raising awareness about the dangers of HIV/AIDS. (c) Discouraging the irrational and over-the-counter sale of critical antibiotics. (d) Indicating the maximum retail price (MRP) on medicine packaging.

Answer: (c) Discouraging the irrational and over-the-counter sale of critical antibiotics. Explanation: The Union Health Ministry’s “Red Line Campaign” urges people not to use medicines marked with a red vertical line without a doctor’s prescription. This line is present on the packaging of antibiotics and other potent drugs to signify that they are prescription-only and to curb their misuse, which is a key driver of AMR.

Mains Practice Question

Question (15 Marks): “Anti-Microbial Resistance (AMR) is a silent pandemic that threatens to undermine decades of medical progress. Critically analyze India’s National Action Plan on AMR, highlighting the challenges in its implementation, especially within the context of the ‘One Health’ framework. Suggest innovative measures to strengthen the response.”

Mind Map Outline (Revision Structure)

• Anti-Microbial Resistance (AMR)
  • Core Concept
    • Definition: Microbes evolving to resist medicines.
    • Mechanism: Natural selection and genetic mutation.
    • Impact: Higher mortality, increased healthcare costs, threat to modern medicine.
  • Key Drivers in the Indian Context
    • Human Health Sector
      • Over-prescription and misuse of antibiotics.
      • Unregulated over-the-counter (OTC) sales.
      • Poor infection prevention and control (IPC) in healthcare facilities.
    • Agriculture & Animal Sector
      • Use of antibiotics as growth promoters in poultry and livestock.
      • Contamination from aquaculture.
      • Transmission of resistant bacteria through the food chain.
    • Environmental Contamination
      • Effluents from pharmaceutical manufacturing units.
      • Untreated sewage and hospital waste.
  • India’s Policy & Legal Framework
    • National Action Plan on AMR (NAP-AMR, 2017)
      • Guiding Principle: ‘One Health’ Approach
        • Integration of human, animal, and environmental health.
      • Six Strategic Pillars (Mnemonic: AKIORI)
        • Awareness and Understanding (e.g., Red Line Campaign).
        • Knowledge and Surveillance (e.g., ICMR AMR Surveillance Network).
        • Infection Prevention and Control.
        • Optimization of Antimicrobial Use (Antibiotic Stewardship).
        • Research and Innovation.
        • Investment and Collaboration.
      • Recent Developments (2024-2025)
        • Expansion of ICMR surveillance network.
        • Proposed Pharmacy (Amendment) Bill, 2024.
        • Operationalization via National One Health Mission.
  • Critical Appraisal
    • Challenges
      • Implementation gaps between policy and practice.
      • Federal coordination (Centre-State).
      • Regulating the informal healthcare sector.
    • Opportunities
      • Leveraging India’s IT strength for digital prescription tracking.
      • Role as “pharmacy of the world” to lead in R&D.
      • Strong global partnerships.